Mixed
Current global supplies of EPA and DHA from traditional marine sources are insufficient to meet human nutritional requirements, creating a supply-demand gap of over 0.4 to 1 million tonnes annually.
You cannot rely on current global fish stocks alone to meet recommended Omega-3 intake levels for everyone. The system is already strained. Consumers should look for products fortified with novel, sustainable sources of EPA/DHA (like algae oils) to ensure adequate intake without contributing to overfishing.
all three studies came to the same conclusion, that the available supply of n-3 LC-PUFA was insufficient to meet the demand to satisfy human requirements [2,8,15].
Why this rating
Based on multiple independent studies cited (references 2, 8, 15) and consensus among health agencies, though specific primary data is not presented in this review.
Source
Omega-3 Long-Chain Polyunsaturated Fatty Acids, EPA and DHA: Bridging the Gap between Supply and Demand
Douglas R. Tocher et al. · Nutrients · 2019
DOI 10.3390/nu11010089
More from this paper
- Replacing fish oil with vegetable oils in aquaculture feeds reduces the EPA/DHA content of farmed fish, negatively impacting the nutritional quality for human consumers.Good
- Novel sources of EPA and DHA, such as genetically modified oilseed crops (canola/camelina) and microalgae, can fully replace fish oil in aquaculture feeds without negative impacts on fish growth or health.Good
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →